$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

$ntip Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000107261324000334 Filed on March 08, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$1.781M	$2.601M
YoY Change
Cost Of Revenue	$0.00	$642.0K	$874.0K
YoY Change	-100.0%
Gross Profit	$0.00	$1.139M	$1.727M
YoY Change	-100.0%
Gross Profit Margin		63.95%	66.4%
Selling, General & Admin	$888.0K	$1.160M	$3.696M
YoY Change	-17.7%	-7.27%	3.04%
% of Gross Profit		101.84%	214.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$30.00K	$30.00K	$266.0K
YoY Change	-63.86%	-63.86%	-15.82%
% of Gross Profit		2.63%	15.4%
Operating Expenses	$918.0K	$1.190M	$4.836M
YoY Change	-30.08%	-10.79%	23.9%
Operating Profit	-$918.0K	-$51.00K	-$2.235M
YoY Change	18.3%	-96.18%	-42.74%
Interest Expense	$479.0K	$812.0K	$2.393M
YoY Change	-28.93%	24.73%	-32.63%
% of Operating Profit
Other Income/Expense, Net	$479.0K		$2.393M
YoY Change	-28.93%		-37.41%
Pretax Income	-$439.0K	$761.0K	$158.0K
YoY Change	330.39%	-211.42%	-297.5%
Income Tax	-$147.0K	-$97.00K	-$388.0K
% Of Pretax Income		-12.75%	-245.57%
Net Earnings	-$920.0K	$452.0K	-$1.457M
YoY Change	47.67%	-126.46%	-37.36%
Net Earnings / Revenue		25.38%	-56.02%
Basic Earnings Per Share	-$0.04		-$0.06
Diluted Earnings Per Share	-$0.04	$0.02	-$0.06
COMMON SHARES
Basic Shares Outstanding	23.51M shares	23.63M shares	23.79M shares
Diluted Shares Outstanding	23.54M shares		23.79M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$43.39M	$45.47M	$45.47M
YoY Change	-7.35%	-6.14%	-6.14%
Cash & Equivalents	$18.11M	$16.90M	$16.90M
Short-Term Investments	$25.29M	$28.57M	$28.57M
Other Short-Term Assets	$218.0K	$206.0K	$206.0K
YoY Change	83.19%	-40.8%	-60.76%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$43.61M	$45.67M	$45.67M
YoY Change	-7.47%	-6.72%	-6.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$75.00K	$16.00K	$16.00K
YoY Change	-48.28%	-90.06%	-90.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$4.621M	$5.249M	$5.249M
YoY Change	-29.75%	-27.62%	-27.62%
Other Assets	$13.00K	$13.00K	$13.00K
YoY Change	0.0%
Total Long-Term Assets	$6.005M	$6.604M	$6.604M
YoY Change	-27.17%	-26.66%	-26.66%
TOTAL ASSETS
Total Short-Term Assets	$43.61M	$45.67M	$45.67M
Total Long-Term Assets	$6.005M	$6.604M	$6.604M
Total Assets	$49.62M	$52.28M	$52.28M
YoY Change	-10.41%	-9.82%	-9.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$306.0K	$125.0K	$125.0K
YoY Change	-49.08%	-75.35%	-75.35%
Accrued Expenses	$239.0K	$88.00K	$698.0K
YoY Change	-53.77%	-91.05%	-28.99%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$545.0K	$823.0K	$823.0K
YoY Change	-55.8%	-48.72%	-48.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$24.00K	$0.00	$0.00
YoY Change	-68.83%	-100.0%	-100.0%
Total Long-Term Liabilities	$24.00K	$0.00	$0.00
YoY Change	-68.83%	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$545.0K	$823.0K	$823.0K
Total Long-Term Liabilities	$24.00K	$0.00	$0.00
Total Liabilities	$1.184M	$1.585M	$1.585M
YoY Change	-48.92%	-44.58%	-44.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.36M	-$16.99M
YoY Change	35.76%	40.93%
Common Stock	$235.0K	$235.0K
YoY Change	-1.67%	-1.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.43M	$50.69M	$50.69M
YoY Change
Total Liabilities & Shareholders Equity	$49.62M	$52.28M	$52.28M
YoY Change	-10.41%	-9.82%	-9.82%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$920.0K	$452.0K	-$1.457M
YoY Change	47.67%	-126.46%	-37.36%
Depreciation, Depletion And Amortization	$30.00K	$30.00K	$266.0K
YoY Change	-63.86%	-63.86%	-15.82%
Cash From Operating Activities	-$596.0K	$1.084M	$331.0K
YoY Change	105.52%	-523.44%	-106.09%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$3.262M	-$4.813M	$6.537M
YoY Change	-296.62%	-31.57%	-130.06%
Cash From Investing Activities	$3.262M	-$4.813M	$6.537M
YoY Change	-296.62%	-31.57%	-129.35%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$966.0K
YoY Change			80.9%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$1.457M	-261.0K	-$3.420M
YoY Change	-7.78%	-38.88%	2.33%
NET CHANGE
Cash From Operating Activities	-$596.0K	1.084M	$331.0K
Cash From Investing Activities	$3.262M	-4.813M	$6.537M
Cash From Financing Activities	-$1.457M	-261.0K	-$3.420M
Net Change In Cash	$1.209M	-3.990M	$3.448M
YoY Change	-134.26%	-48.29%	-111.11%
FREE CASH FLOW
Cash From Operating Activities	-$596.0K	$1.084M	$331.0K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	nssi	Cost Of Revenues CostOfRevenues		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001065078
CY2023Q4	us-gaap	Prepaid Taxes PrepaidTaxes		usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit		usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment		usd
CY2023	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment		usd
CY2023	nssi	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2023	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments		usd
CY2023	us-gaap	Interest Paid InterestPaid		usd
CY2022	us-gaap	Interest Paid InterestPaid		usd
CY2023	nssi	Non Cash Conversion Of Note Receivable NonCashConversionOfNoteReceivable		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2022	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants		shares
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards		usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther		usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour		usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive		usd
CY2023Q4	nssi	Operating Leases Imputed Interest OperatingLeasesImputedInterest		usd
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	1-15288
CY2023	dei	Entity Registrant Name EntityRegistrantName	NETWORK-1 TECHNOLOGIES, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-3027591
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	65 Locust Avenue
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Third Floor
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	New Canaan
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06840
CY2023	dei	City Area Code CityAreaCode	(203)
CY2023	dei	Local Phone Number LocalPhoneNumber	920-1055
CY2023	dei	Security12b Title Security12bTitle	Common Stock $.01 par value
CY2023	dei	Trading Symbol TradingSymbol	NTIP
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	38052926	usd
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	23510019	shares
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	688
CY2023	dei	Auditor Name AuditorName	Marcum llp
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16896000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13448000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	28571000	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	34991000	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	177000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	206000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	348000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	45673000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	48964000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1326000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1592000	usd
CY2023Q4	us-gaap	Equity Method Investments EquityMethodInvestments	5249000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	7252000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161000	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	13000	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	6604000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	9005000	usd
CY2023Q4	us-gaap	Assets Assets	52277000	usd
CY2022Q4	us-gaap	Assets Assets	57969000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	125000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	507000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	115000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	378000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	317000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	297000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	587000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	823000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1605000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	762000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1161000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	1585000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2860000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23553908	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23553908	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23863639	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23863639	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	235000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	239000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	67446000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66939000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16989000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12055000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	50692000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	55109000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	52277000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	57969000	usd
CY2023	us-gaap	Revenues Revenues	2601000	usd
CY2023	nssi	Cost Of Revenues CostOfRevenues	874000	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	807000	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	809000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2889000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2778000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	266000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	316000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4836000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3903000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2235000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3903000	usd
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1868000	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1020000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2022	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment	3883000	usd
CY2023	nssi	Net Realized And Unrealized Gain Loss On Marketable Securities NetRealizedAndUnrealizedGainLossOnMarketableSecurities	525000	usd
CY2022	nssi	Net Realized And Unrealized Gain Loss On Marketable Securities NetRealizedAndUnrealizedGainLossOnMarketableSecurities	-1351000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2393000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3823000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	158000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Interest Expense Interest Income Income Taxes Extraordinary Items Noncontrolling Interests Net IncomeLossFromContinuingOperationsBeforeInterestExpenseInterestIncomeIncomeTaxesExtraordinaryItemsNoncontrollingInterestsNet	-80000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-399000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	607000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-388000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	607000	usd
CY2023	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	546000	usd
CY2022	nssi	Loss Income Before Share Of Net Losses Of Equity Method Investee LossIncomeBeforeShareOfNetLossesOfEquityMethodInvestee	-687000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-2003000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-1639000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1457000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2326000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23791287	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23825917	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23791287	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23825917	shares
CY2023	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2022	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.10
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-1457000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-2326000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	14000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Before Reclassifications Net Of Tax OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax	-2000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1443000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2328000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1457000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2326000	usd
CY2023	us-gaap	Adjustment For Amortization AdjustmentForAmortization	266000	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	316000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	508000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	585000	usd
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-2003000	usd
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-1639000	usd
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	-399000	usd
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	607000	usd
CY2023	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	65000	usd
CY2022	nssi	Amortization Of Right Of Use Asset AmortizationOfRightOfUseAsset	43000	usd
CY2022	nssi	Gain On Equity Method Investment GainOnEquityMethodInvestment	3883000	usd
CY2022	nssi	Accrued Interest On Convertible Note AccruedInterestOnConvertibleNote	86000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	103000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-880000	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-142000	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	208000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-177000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	167000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-382000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	48000	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-115000	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-2837000	usd
CY2023	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	-13000	usd
CY2022	us-gaap	Increase Decrease In Security Deposits IncreaseDecreaseInSecurityDeposits	13000	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-70000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-31000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-291000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	242000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	331000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5436000	usd
CY2023	nssi	Sales Of Marketable Securities SalesOfMarketableSecurities	-53521000	usd
CY2022	nssi	Sales Of Marketable Securities SalesOfMarketableSecurities	-13156000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	46984000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	33903000	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	524000	usd
CY2022	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	6537000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22271000	usd
CY2023	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2371000	usd
CY2022	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2453000	usd
CY2023	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes	83000	usd
CY2022	nssi	Value Of Shares Delivered To Fund Withholding Taxes ValueOfSharesDeliveredToFundWithholdingTaxes	355000	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	966000	usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	534000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3420000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3342000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3448000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-31049000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13448000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	44497000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16896000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13448000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	65000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3004000	usd
CY2023	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	65000	usd
CY2022	nssi	Accrued Dividend Rights On Restricted Stock Units AccruedDividendRightsOnRestrictedStockUnits	37000	usd
CY2023	nssi	Modification Of Rightofuse Asset ModificationOfRightofuseAsset	80000	usd
CY2022	nssi	Modification Of Rightofuse Asset ModificationOfRightofuseAsset	204000	usd
CY2022	nssi	Non Cash Conversion Of Note Receivable NonCashConversionOfNoteReceivable	1086000	usd
CY2023	us-gaap	Gain Contingency Patents Found Infringed Upon Number GainContingencyPatentsFoundInfringedUponNumber	100	integer
CY2023	nssi	Expired Patents ExpiredPatents	54	integer
CY2023	nssi	Foreign Patents Owned By Company ForeignPatentsOwnedByCompany	15	integer
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zAW1JvmlsZZj" style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0pt 12pt 27.35pt; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 12pt"><tr style="vertical-align: top"> <td style="width: 0"></td><td style="width: 0.35in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b>[2]</b></span></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><b><span id="xdx_86D_zZUZ1Z2SlGK8">Use of Estimates and Assumptions</span></b></span></td></tr></table> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. The estimates and assumptions made in the preparation of the Company’s consolidated financial statements primarily include costs related to the Company’s assertion of litigation, the valuation of the Company’s patent portfolios, stock-based compensation, the recoverability of deferred tax assets and the carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates, upon which the carrying values were based. </span></p> <p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 12pt 27.35pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Certain amounts recorded to reflect the Company’s share of the income or losses of its equity method investee, accounted for under the equity method, are based on estimates and the unaudited results of operations of the equity method investee, and may require adjustment in the future when the audit is complete. The Company reports its share of the results of its equity method investee on a one quarter lag basis.</span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	2403000	usd
CY2022Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1715000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	15327000	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	5316000	usd
CY2023Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	6077000	usd
CY2022Q4	us-gaap	Certificates Of Deposit At Carrying Value CertificatesOfDepositAtCarryingValue	2976000	usd
CY2023	us-gaap	Revenues Revenues	2601000	usd
CY2023Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	8473000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7147000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6881000	usd
CY2023Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1326000	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1592000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	266000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	316000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	120000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	120000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	120000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	119000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	116000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	731000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1326000	usd
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	587500	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	625000	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23791287	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23825917	shares
CY2023	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23791287	shares
CY2022	nssi	Weightedaverage Common Shares Outstanding Diluted WeightedaverageCommonSharesOutstandingDiluted	23825917	shares
CY2023	nssi	Restricted Stock Units Excluded From Computation Of Diluted Income Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	587500	shares
CY2022	nssi	Restricted Stock Units Excluded From Computation Of Diluted Income Per Share Because Effect Of Inclusion Would Have Been Antidilutive RestrictedStockUnitsExcludedFromComputationOfDilutedIncomePerShareBecauseEffectOfInclusionWouldHaveBeenAntidilutive	625000	shares
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	11000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-39000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	56000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-360000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	551000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-399000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	607000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-388000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	607000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	804000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	477000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	47000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	331000	usd
CY2023Q4	nssi	Deferred Tax Assets Stock Options And Rsu DeferredTaxAssetsStockOptionsAndRsu	27000	usd
CY2022Q4	nssi	Deferred Tax Assets Stock Options And Rsu DeferredTaxAssetsStockOptionsAndRsu	30000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	148000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	182000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1208000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	838000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1208000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	838000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	762000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1161000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	762000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	1161000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	3364000	usd
CY2023Q4	nssi	Deferred Tax Asset Gross DeferredTaxAssetGross	1201000	usd
CY2023Q4	nssi	Deferred Tax Assets Valuation Allowances DeferredTaxAssetsValuationAllowances	1201000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	762000	usd
CY2023	us-gaap	Debt Securities Unrealized Gain Loss DebtSecuritiesUnrealizedGainLoss	3883000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0019	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.084	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.0198	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4879	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0246	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0128	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0043	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.2129	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	-0.3534	pure
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	625000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.87
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	12500	shares
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	3.36
CY2023	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	120000	shares
CY2023	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	2.27
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	670000	shares
CY2022	nssi	Issuance Weightedaverage Grant Date Fair Value IssuanceWeightedaverageGrantDateFairValue	1.92
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	157500	shares
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.43
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares	57500	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.73
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	587500	shares
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.81
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	625000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	1.87
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	94000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1000000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	86000	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	271000	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	24272000	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	15246000	usd
CY2023	nssi	Comprehensive Loss ComprehensiveLoss	29532000	usd
CY2022	nssi	Comprehensive Loss ComprehensiveLoss	17913000	usd
CY2023	nssi	Contingency Fee Minimum ContingencyFeeMinimum	0.15	pure
CY2023	nssi	Contingency Fee Maximum ContingencyFeeMaximum	0.24	pure
CY2023	nssi	Legal Fees On Full Contingency Minimum LegalFeesOnFullContingencyMinimum	0.15	pure
CY2023	nssi	Legal Fees On Full Contingency Maximum LegalFeesOnFullContingencyMaximum	0.30	pure
CY2023	nssi	Legal Fees On Contingency Basis Minimum Remote Power Patent LegalFeesOnContingencyBasisMinimumRemotePowerPatent	0.15	pure
CY2023	nssi	Legal Fees On Contingency Basis Maximum Remote Power Patent LegalFeesOnContingencyBasisMaximumRemotePowerPatent	0.40	pure
CY2023	nssi	Contingent Fees And Accrued Expenses ContingentFeesAndAccruedExpenses	744000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	88000	usd
CY2022Q1	nssi	Hft Patent Acqusition Cash At Closing HftPatentAcqusitionCashAtClosing	500000	usd
CY2022Q1	nssi	Obligation To Pay Hft Seller Additional Cash Based On Achieving Certain Milestones ObligationToPayHftSellerAdditionalCashBasedOnAchievingCertainMilestones	500000	usd
CY2022Q1	nssi	Contingent Common Stock Issued Upon Achieving Certain Milestones ContingentCommonStockIssuedUponAchievingCertainMilestones	375000	usd
CY2022Q1	nssi	First50 Million First50Million	0.15	pure
CY2022Q1	nssi	Greater Than50 Million GreaterThan50Million	0.175	pure
CY2023Q4	nssi	Obligated To Pay Seller Net Proceed Percentage ObligatedToPaySellerNetProceedPercentage	0.125	pure
CY2023Q4	nssi	First125 Million First125Million	0.10	pure
CY2023Q4	nssi	Next125 Million Next125Million	0.15	pure
CY2023Q4	nssi	Over250 Million Over250Million	0.20	pure
	nssi	Recognition Net Proceeds Payment Related To Mirror Worlds Patents RecognitionNetProceedsPaymentRelatedToMirrorWorldsPatents	3127000	usd
CY2023Q4	nssi	First100 First100	0.14	pure
CY2023Q4	nssi	Next100 Next100	0.05	pure
CY2023Q4	nssi	Aadditional Consideration AadditionalConsideration	250000	usd
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	73000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	78000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.042	pure
CY2022Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3Y
CY2023Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P3M
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	161000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	173000	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	68000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	48000	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	82000	usd
CY2023	us-gaap	Lease Cost LeaseCost	68000	usd
CY2022	us-gaap	Lease Cost LeaseCost	130000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	23000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	23000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	23000	usd
CY2023	us-gaap	Revenues Revenues	2601000	usd
CY2023	nssi	Non Recognized Revenue NonRecognizedRevenue	150000	usd
CY2023	nssi	Percentage Revenue PercentageRevenue	1	pure
CY2023	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	428132	shares
CY2023	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	955000	usd
CY2023	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	2.23
	us-gaap	Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation	9532982	shares
	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	18713000	usd
	nssi	Weighted Average Price Per Share Common Stock Subject To Repurchase WeightedAveragePricePerShareCommonStockSubjectToRepurchase	1.94
CY2023	nssi	Dividends Per Share Annual DividendsPerShareAnnual	0.10
CY2023	nssi	Dividends Per Share DividendsPerShare	0.05

Files In Submission

Name	View Source	Status
0001072613-24-000334-index-headers.html	Edgar Link	pending
0001072613-24-000334-index.html	Edgar Link	pending
0001072613-24-000334.txt	Edgar Link	pending
0001072613-24-000334-xbrl.zip	Edgar Link	pending
exh19_18806.htm	Edgar Link	pending
exh21-1_18806.htm	Edgar Link	pending
exh23-1_18806.htm	Edgar Link	pending
exh31-1_18806.htm	Edgar Link	pending
exh31-2_18806.htm	Edgar Link	pending
exh32-1_18806.htm	Edgar Link	pending
exh32-2_18806.htm	Edgar Link	pending
exh97_18806.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
network1_10k-123123.htm	Edgar Link	pending
nssi-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
nssi-20231231_cal.xml	Edgar Link	unprocessable
nssi-20231231_def.xml	Edgar Link	unprocessable
nssi-20231231_lab.xml	Edgar Link	unprocessable
nssi-20231231_pre.xml	Edgar Link	unprocessable
network1_10k-123123_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2024 Q1 Form 10-K Financial Statement

#000107261324000334 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP NETWORK-1 TECHNOLOGIES, INC. Stock $ntip

2024 Q1 Form 10-K Financial Statement

#000107261324000334 Filed on March 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTIP
NETWORK-1 TECHNOLOGIES, INC. Stock $ntip